insights_auto
Why is PEB down 6.67%?
Dive Deeperchevron_right
PEB:ASX
Pacific Edge Ltd
A$0.21
arrow_downward
-6.67%(-0.015) 1D
Nov 18, 4:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Open
A$0.23
High
A$0.23
Low
A$0.21
Mkt. cap
336.96M
Avg. vol.
54.38K
Volume
80.41K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
Open
A$0.23
High
A$0.23
Low
A$0.21
Mkt. cap
336.96M
Avg. vol.
54.38K
Volume
80.41K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
News stories
From web sources and news partners
ChartMill
·
58 minutes ago
S&P 500 Most Active Stocks on Nov. 18: AES Leads Volume, Freeport-McMoRan Drops 6.45%
BigGo Finance
·
1 hour ago
S&P 500's Shiller P/E Tops 40 Again, Echoing Dot-Com Era Valuations
ChartMill
·
1 hour ago
S&P 500 Unusual Volume Movers: Nov. 18, 2026
Traders Union
·
44 minutes ago
S&P 500 movement in 1992–2010 often tied to valuation multiples, Brett Caughran notes
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd
CEO-
Employees114
Founded2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepacificedgedx.com